Among privately insured US adolescents who identified as transgender and gender-diverse, receipt of puberty blockers and ...

also known as gender-affirming hormone therapy. For transgender women, this involves not only the use of estrogen (in the form of estradiol) but also the use of a testosterone blocker. This is ...

Just .1% of children ages 8 to 17 who identify as transgender or gender-diverse were prescribed gender-affirming hormones or puberty blockers, according to a study by researchers at Harvard ...

Puberty blockers and gender-affirming hormones are rarely prescribed to U.S. transgender and gender diverse (TGD) adolescents, according to a new study from researchers at Harvard T.H. Chan School of ...

“The politicization of gender-affirming care for transgender youth has been driven by a narrative that millions of children are using hormones and that this type of care is too freely give ...

The study also found that not a single transgender and gender-diverse child under 12 received hormones. Additionally, transgender and gender-diverse teens who were assigned female at birth were ...

Just .1% of children ages 8 to 17 who identify as transgender or gender-diverse were prescribed gender-affirming hormones or puberty blockers, according to a study by researchers at Harvard University ...